Traitement de l'hypertension artérielle chez le sujet obèse [Treatment of hypertension in obese patients].

Détails

ID Serval
serval:BIB_3FE9878B136C
Type
Article: article d'un périodique ou d'un magazine.
Sous-type
Synthèse (review): revue aussi complète que possible des connaissances sur un sujet, rédigée à partir de l'analyse exhaustive des travaux publiés.
Collection
Publications
Institution
Titre
Traitement de l'hypertension artérielle chez le sujet obèse [Treatment of hypertension in obese patients].
Périodique
Revue Médicale Suisse
Auteur(s)
Comte-Perret S., Giusti V., Wuerzner G.
ISSN
1660-9379 (Print)
ISSN-L
1660-9379
Statut éditorial
Publié
Date de publication
2013
Volume
9
Numéro
397
Pages
1622-1626
Langue
français
Notes
Publication types: English Abstract ; Journal ArticlePublication Status: ppublish. pdf type: mise au point...
Résumé
Prevalence of obesity and hypertension has increased these last decades. Around 60 to 70% of the incidence of hypertension is related to obesity. The relationship between obesity and hypertension is now well established. The sympathetic nervous system and the renin-angiotensin-aldosterone (RAA) system are activated in obese patients, mostly by insulin, and predispose the kidney to reabsorb sodium and water. In obese patients with hypertension, it is recommended to target a blood pressure < 140/90 mmHg. Lifestyle changes (weight loss, physical activity, low-salt diets) are useful to decrease blood pressure but are difficult to maintain in the long-term. When drugs are necessary, drugs that are metabolically neutral should be used, and often need to be combined to other drug classes in order to achieve blood pressure target.
Mots-clé
Blood Pressure/physiology, Humans, Hypertension/etiology, Hypertension/physiopathology, Incidence, Insulin/metabolism, Life Style, Obesity/complications, Obesity/physiopathology, Prevalence, Renin-Angiotensin System/physiology, Sympathetic Nervous System/metabolism
Pubmed
Création de la notice
23/12/2013 16:43
Dernière modification de la notice
20/08/2019 14:37
Données d'usage